BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1008080)

  • 1. Current concepts in the management of malignant melanoma.
    Lichtenfeld JL
    Am J Med Sci; 1976; 272(2):185-95. PubMed ID: 1008080
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chemotherapy of malignant melanomas].
    Gallmeier WM
    Haematol Blood Transfus; 1978; 21():293-302. PubMed ID: 367896
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of chemotherapy and immunotherapy on tumor-specific immunity in melanoma.
    Mitchell MS; Mokyr MB; Davis JM
    J Clin Invest; 1977 Jun; 59(6):1017-26. PubMed ID: 863999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results in the use of immunochemotherapy in patients with cutaneous malignant melanoma].
    Calbo L; Gorgone S; Palmeri R; Salibra M; Melita P
    Chir Ital; 1983 Aug; 35(4):519-25. PubMed ID: 6680859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant melanoma (stage IIIB): a pilot study of adjuvant chemo-immunotherapy.
    Paterson AH; McPherson TA; Willans DJ
    Cancer Treat Rep; 1978 Apr; 62(4):571-3. PubMed ID: 350395
    [No Abstract]   [Full Text] [Related]  

  • 6. [Possibilities of immunotherapy in malignant melanoma].
    Lewis MG
    Hautarzt; 1978 Dec; 29(12):619-24. PubMed ID: 363650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemoimmunotherapy stage I/II malignant melanoma.
    Knost JA; Reynolds V; Greco FA; Oldham RK
    J Surg Oncol; 1982 Mar; 19(3):165-70. PubMed ID: 7040820
    [No Abstract]   [Full Text] [Related]  

  • 8. The survival of patients with malignant melanoma receiving BCG with or without chemotherapy.
    Green MD; MacKay IR; Buckley JC; Coates AS
    Aust N Z J Surg; 1979 Jun; 49(3):335-9. PubMed ID: 289374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fotemustine in the treatment of metastatic malignant melanoma. Overall analysis of results].
    Pathol Biol (Paris); 1990 Oct; 38(8):876-80. PubMed ID: 2274396
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chemotherapy of malignant melanoma].
    Karakousis CP
    Chirurg; 1986 Oct; 57(10):606-11. PubMed ID: 3792110
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experience with adjuvant chemoimmunotherapy with DTIC and BCG in malignant melanoma (author's transl)].
    Pullmann H; Muth M
    Z Hautkr; 1982 Feb; 57(4):294-7. PubMed ID: 7080583
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adjuvant chemotherapy in malignant melanoma after pretherapeutic sensitivity testing].
    Zaumseil RP; Wohlrab W; Fiedler H; Wozniak KD
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):721-4. PubMed ID: 6172340
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapy of unresectable or recurrent metastatic malignant melanomas: an update.
    Block JB; Tabbarah H; Isacoff W; Drakes TP
    J Dermatol Surg Oncol; 1979 Feb; 5(2):118-23. PubMed ID: 762295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of immunochemotherapy in malignant melanoma].
    Duchková H; Richter J; Kubíková M; Peska J; Ragan J; Vohryzková E; Hrivnáková J; Kvasnicka J
    Cesk Dermatol; 1980 Aug; 55(4):277-80. PubMed ID: 7407970
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current results with surgery and adjuvant chemotherapy in malignant melanoma].
    Mechl Z; Kopecný J
    Arch Geschwulstforsch; 1986; 56(5):367-71. PubMed ID: 2429631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter: Chemoimmunotherapy of malignant melanoma.
    N Engl J Med; 1975 Jan; 292(3):159-60. PubMed ID: 1196343
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunological aspects in the treatment of malignant melanoma].
    Cascinelli N; Vaglini M; Rovini D; Orefice S; Marolda R; Veronesi U
    Minerva Med; 1982 Apr; 73(18):1233-40. PubMed ID: 7078802
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunotherapy for recurrent malignant melanoma: efficacy of BCG in prolonging the postoperative disease-free interval and survival.
    Gutterman JU; Richman SP; McBride CM; Burgess MA; Bartold SL; Kennedy A; Gehan EA; Mavligit G; Hersh EM
    Recent Results Cancer Res; 1978; 68():359-62. PubMed ID: 752870
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumour regression and survival of patients with disseminated malignant melanoma treated with chemotherapy and specific active immunotherapy.
    Hedley DW; McElwain TJ; Currie GA
    Eur J Cancer (1965); 1977 Oct; 13(10):1169-73. PubMed ID: 923614
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemotherapy of malignant melanoma.
    Benjamin RS
    World J Surg; 1979 Jul; 3(3):321-8. PubMed ID: 382646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.